{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:08Z","timestamp":1707524528971},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,13]]},"DOI":"10.7759\/cureus.24129","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T01:52:42Z","timestamp":1649901162000},"source":"Crossref","is-referenced-by-count":0,"title":["A Review of the Treatment of Herpes Simplex Virus-1 Encephalitis in Six Immunocompetent Patients"],"prefix":"10.7759","author":[{"given":"Edwin","family":"McCray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tripp","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vipul","family":"Savaliya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2006.04.002","article-title":"Herpes simplex encephalitis: adolescents and adults","volume":"71","author":"Whitley RJ","year":"2006","unstructured":"Whitley RJ. Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 2006, 71:141-8. 10.1016\/j.antiviral.2006.04.002","journal-title":"Antiviral Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0046-8177(98)90038-7","article-title":"Herpes simplex encephalitis (HSE) and the immunocompromised: A clinical and autopsy study of HSE in the settings of cancer and human immunodeficiency virus-type 1 infection","volume":"1998","author":"Schiff D","unstructured":"Schiff D, Rosenblum MK. Herpes simplex encephalitis (HSE) and the immunocompromised: A clinical and autopsy study of HSE in the settings of cancer and human immunodeficiency virus-type 1 infection. Hum Pathol. 1998:215-222. 10.1016\/s0046-8177(98)90038-7","journal-title":"Hum Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0147-9563(98)90009-7","article-title":"Herpes simplex encephalitis: a review","volume":"27","author":"Levitz RE","year":"1998","unstructured":"Levitz RE. Herpes simplex encephalitis: a review. Heart Lung. 1998, 27:209-12. 10.1016\/s0147-9563(98)90009-7","journal-title":"Heart Lung"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(84)92623-0","article-title":"Acyclovir versus vidarabine in herpes simplex encephalitis. randomised multicentre study in consecutive swedish patients","volume":"1984","author":"Sk\u00f6ldenberg B","unstructured":"Sk\u00f6ldenberg B, Forsgren M, Alestig K, et al.. Acyclovir versus vidarabine in herpes simplex encephalitis. randomised multicentre study in consecutive swedish patients. Lancet. 1984:707-711. 10.1016\/s0140-6736(84)92623-0","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198601163140303","article-title":"Vidarabine versus acyclovir therapy in herpes simplex encephalitis","volume":"314","author":"Whitley RJ","year":"1986","unstructured":"Whitley RJ, Alford CA, Hirsch MS, et al.. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986, 314:144-9. 10.1056\/NEJM198601163140303","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-016-0433-7","article-title":"Herpes simplex virus-1 encephalitis in adults: pathophysiology, diagnosis, and management","volume":"13","author":"Bradshaw MJ","year":"2016","unstructured":"Bradshaw MJ, Venkatesan A. Herpes simplex virus-1 encephalitis in adults: pathophysiology, diagnosis, and management. Neurotherapeutics. 2016, 13:493-508. 10.1007\/s13311-016-0433-7","journal-title":"Neurotherapeutics"},{"key":"ref7","article-title":"Herpes simplex encephalitis","author":"Ak AK","year":"2021","unstructured":"Ak AK, Mendez MD. Herpes simplex encephalitis. StatPearls [Internet]. StatPearls Publishing, Treasure Island, Florida; 2021."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2017.06.006","article-title":"Herpes virus encephalitis in adults: current knowledge and old myths","volume":"35","author":"Rabinstein AA","year":"2017","unstructured":"Rabinstein AA. Herpes virus encephalitis in adults: current knowledge and old myths. Neurol Clin. 2017, 35:695-705. 10.1016\/j.ncl.2017.06.006","journal-title":"Neurol Clin"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/BF01650104","article-title":"Factors indicative of outcome in a comparative trial of acyclovir and vidarabine for biopsy-proven herpes simplex encephalitis","volume":"15","author":"Whitley RJ","year":"1987","unstructured":"Whitley RJ, Alford CA, Hirsch MS, et al.. Factors indicative of outcome in a comparative trial of acyclovir and vidarabine for biopsy-proven herpes simplex encephalitis. Infection. 1987, 15:S3-8. 10.1007\/BF01650104","journal-title":"Infection"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ369","article-title":"Herpes simplex encephalitis: lack of clinical benefit of long-term valacyclovir therapy","volume":"61","author":"Gnann JW Jr","year":"2015","unstructured":"Gnann JW Jr, Sk\u00f6ldenberg B, Hart J, et al.. Herpes simplex encephalitis: lack of clinical benefit of long-term valacyclovir therapy. Clin Infect Dis. 2015, 61:683-91. 10.1093\/cid\/civ369","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.18-2-155","article-title":"Acute encephalitis - diagnosis and management","volume":"18","author":"Ellul M","year":"2018","unstructured":"Ellul M, Solomon T. Acute encephalitis - diagnosis and management. Clin Med (Lond). 2018, 18:155-9. 10.7861\/clinmedicine.18-2-155","journal-title":"Clin Med (Lond)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-017-3115-2","article-title":"Concomitant neurosyphilis and herpes simplex encephalitis in an immunocompetent patient: a case report","volume":"39","author":"Escobar-Valdivia E","year":"2018","unstructured":"Escobar-Valdivia E, Medina-Pi\u00f1\u00f3n I, Garc\u00eda-Sarreon A, Camara-Lemarroy CR. Concomitant neurosyphilis and herpes simplex encephalitis in an immunocompetent patient: a case report. Neurol Sci. 2018, 39:185-7. 10.1007\/s10072-017-3115-2","journal-title":"Neurol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-016-0489-5","article-title":"Acyclovir resistance in herpes simplex virus type I encephalitis: a case report","volume":"23","author":"Bergmann M","year":"2017","unstructured":"Bergmann M, Beer R, Kofler M, Helbok R, Pfausler B, Schmutzhard E. Acyclovir resistance in herpes simplex virus type I encephalitis: a case report. J Neurovirol. 2017, 23:335-7. 10.1007\/s13365-016-0489-5","journal-title":"J Neurovirol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017001","article-title":"Fulminant bilateral acute retinal necrosis complicated with secondary herpes simplex type-1 viral encephalitis: A case report","volume":"98","author":"Ye L","year":"2019","unstructured":"Ye L, Ding X, Shen S, Wang J, Wu J, Chen Y. Fulminant bilateral acute retinal necrosis complicated with secondary herpes simplex type-1 viral encephalitis: A case report. Medicine (Baltimore). 2019, 98:e17001. 10.1097\/MD.0000000000017001","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21979","article-title":"Acyclovir resistance in herpes simplex encephalitis","volume":"67","author":"Schulte EC","year":"2010","unstructured":"Schulte EC, Sauerbrei A, Hoffmann D, Zimmer C, Hemmer B, M\u00fchlau M. Acyclovir resistance in herpes simplex encephalitis. Ann Neurol. 2010, 67:830-3. 10.1002\/ana.21979","journal-title":"Ann Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.2002.800517.x","article-title":"Herpes simplex virus type 1 encephalitis associated with acute retinal necrosis syndrome in an immunocompetent patient","volume":"80","author":"Gain P","year":"2002","unstructured":"Gain P, Chiquet C, Thuret G, Drouet E, Antoine JC. Herpes simplex virus type 1 encephalitis associated with acute retinal necrosis syndrome in an immunocompetent patient. Acta Ophthalmol Scand. 2002, 80:546-9. 10.1034\/j.1600-0420.2002.800517.x","journal-title":"Acta Ophthalmol Scand"},{"key":"ref17","article-title":"A fatal case of Herpes simplex virus meningoencephalitis in an immunocompetent adult (Article in French)","volume":"61","author":"Andr\u00e9oletti L","year":"2003","unstructured":"Andr\u00e9oletti L, Bouscambert M, Pichenot V, Brodard V, Cousson J, L\u00e9on A. A fatal case of Herpes simplex virus meningoencephalitis in an immunocompetent adult (Article in French). Ann Biol Clin (Paris). 2003, 61:585-8.","journal-title":"Ann Biol Clin (Paris)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001153","article-title":"The longitudinal health economic impact of viral encephalitis in the United States","volume":"69","author":"Kiyani M","year":"2020","unstructured":"Kiyani M, Liu B, Charalambous LT, et al.. The longitudinal health economic impact of viral encephalitis in the United States. J Med Microbiol. 2020, 69:270-9. 10.1099\/jmm.0.001153","journal-title":"J Med Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1086\/514584","article-title":"Perspectives on switching oral acyclovir from prescription to over-the-counter status: report of a consensus panel","volume":"26","author":"Sande MA","year":"1998","unstructured":"Sande MA, Armstrong D, Corey L, Drew WL, Gilbert D, Moellering RC Jr, Smith LG. Perspectives on switching oral acyclovir from prescription to over-the-counter status: report of a consensus panel. Clin Infect Dis. 1998, 26:659-63. 10.1086\/514584","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.04.002","article-title":"Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization","volume":"32","author":"Str\u00e1nsk\u00e1 R","year":"2005","unstructured":"Str\u00e1nsk\u00e1 R, Schuurman R, Nienhuis E, et al.. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J Clin Virol. 2005, 32:7-18. 10.1016\/j.jcv.2004.04.002","journal-title":"J Clin Virol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/69087-a-review-of-the-treatment-of-herpes-simplex-virus-1-encephalitis-in-six-immunocompetent-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:46Z","timestamp":1707507406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/69087-a-review-of-the-treatment-of-herpes-simplex-virus-1-encephalitis-in-six-immunocompetent-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.24129","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,13]]}}}